Back to directory

Fondazione Toscana Gabriele Monasterio

Fondazione Toscana Gabriele Monasterio

AL Amyloidosis ATTRv ATTRwt AA Amyloidosis 1 Rare Subtype

Contact Information

Primary Contact

Alberto Aimo

Cardiologist, researcher

Activity level

  • Patients per year300
  • New diagnoses per year80

Multidisciplinary team

  • HematologyThrough formal referral
  • CardiologyOn-site
  • NephrologyThrough formal referral
  • NeurologyThrough formal referral
  • PathologyThrough formal referral
Other specialists
PulmonologyPrimary CareGeneticistsGenetic counsellorsNuclear medicine specialistsCardiac imaging specialistsRadiologistsTransplant programme - heartPalliative carePsychology / counselling

Diagnostic capabilities

  • EchocardiographyOn-site
  • Cardiac MRI (CMR)On-site
  • Radionuclide imagingOn-site
  • Histopathology (Congo red)Through network partners
  • Amyloid typingOn-site
  • Genetic testingOn-site
  • Fat aspiration / labial gland biopsyThrough network partners
  • Organ biopsiesThrough network partners
Partner laboratories

Azienda Ospedaliero Universitaria Pisana (Surgical Anatomy Unit)

Subtype expertise

  • ALYes
  • ATTRvYes
  • ATTRwtYes
  • AAYes
Rare subtypes
Apolipoprotein A-IV (AApoAIV)

Treatment options

  • Chemotherapy (AL)Available via formal referral
  • TTR stabilizersAvailable on-site
  • RNA interferenceAvailable on-site
  • Antisense oligonucleotidesAvailable on-site
  • Stem cell transplantAvailable via formal referral
  • Heart transplantAvailable via formal referral
  • Kidney transplantAvailable via formal referral
  • Liver transplantAvailable via formal referral

Patient support services

Services offered
Psychosocial supportGenetic counsellingNutritional guidance (dietitian)Specialty pharmacyPalliative care

Networks & telemedicine

  • Telemedicine / virtual consultationYes
  • Part of a formal amyloidosis networkYes
  • Diagnostic services for other organisationsYes
Network webpage
Diagnostic services contact

Last confirmed: 5 April 2026

Listings are self-reported by each center and have not been independently verified by the International Society of Amyloidosis (ISA). Inclusion in this directory does not constitute certification, accreditation, or endorsement by ISA.